Cyclo Therapeutics Inc (CYTH)

[NPC1Parent]

I believe they are in Phase I, so not a chance in Hell. It takes a long time to get a drug approved. Even "Fast Track" drugs.

That said, CTDH success does not depend drug approval by September. It depends on their ability to raise money. So far, they have been pretty resourceful. I wouldn't count them out.

In terms of FDA approval, it looks like the Orphazyme drug will approved before either CTDH or MNK. This came out yesterday.

https://www.globenewswire.com/news-release/2019/11/19/1949080/0/en/Orphazyme-receives-Breakthrough-Therapy-Designation-for-arimoclomol-in-Niemann-Pick-Disease-Type-C-NPC.html

I don't know what effect that will have on CTDH or MNK. Hopefully no effect. I want every company treating NPC1 to succeed.